Abstract
Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.
| Original language | English |
|---|---|
| Pages (from-to) | 1335-1342 |
| Number of pages | 8 |
| Journal | Urology |
| Volume | 75 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2010 |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease : An Analysis and Comparison of Perioperative Outcome. / Bird, Vincent G.; Shields, John M.; Aziz, Mohammed; De Los Santos, Rosely; Ayyathurai, Rajnikanth; Ciancio, Gaetano.
In: Urology, Vol. 75, No. 6, 01.06.2010, p. 1335-1342.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transperitoneal Laparoscopic Radical Nephrectomy for Patients With Dialysis-dependent End-stage Renal Disease
T2 - An Analysis and Comparison of Perioperative Outcome
AU - Bird, Vincent G.
AU - Shields, John M.
AU - Aziz, Mohammed
AU - De Los Santos, Rosely
AU - Ayyathurai, Rajnikanth
AU - Ciancio, Gaetano
PY - 2010/6/1
Y1 - 2010/6/1
N2 - Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.
AB - Objectives: To evaluate LRN as treatment for high risk patients. Laparoscopic radical nephrectomy (LRN) is performed for renal tumors not amenable to nephron-sparing treatments. Indications are increasing to include higher risk patients including those with end-stage renal disease (ESRD) necessitating dialysis. Methods: We performed a retrospective analysis of a patient cohort with clinical stage T1 renal tumors undergoing transperitoneal LRN. Parameters examined included patient demographics, medical comorbidities, tumor characteristics, operative outcomes, and complications. Results: One hundred eighty-nine patients underwent 195 LRN. Sixteen patients (8.5%) had preexistent ESRD requiring dialysis. A higher American Society of Anesthiologists score (P <.05), higher age-adjusted Charlson comorbidity index (P = .003), higher incidence of previous abdominal surgery (P = .012), and higher incidence of hypertension (P = .025) were found for the ESRD group. Mean blood loss was 153.0 and 132.0 mL (P = .71) in the ESRD patients and non-ESRD patients, respectively. A longer stay (P = .02) was noted for ESRD patients. Mean tumor size in the ESRD patients and non-ESRD patients was 2.6 and 4.2 cm (P <.05), respectively. Renal cell carcinoma was the most common pathology in 14 of 20 (70.0%) ESRD patient renal units and 167 of 175 (95.4%) non-ESRD patient renal units (P = .001). Intraoperative and postoperative complication rates were 6.3% and 31.3% respectively for ESRD patients (P = .05), and 8.7% and 21.4% respectively for non-ESRD patients (P = .35). Most postoperative complications were minor. Conclusions: LRN, for the treatment of renal tumors in ESRD patients requiring dialysis, is feasible and safe with acceptable intraoperative and postoperative complication rates. Patients with ESRD may require longer hospital stay after LRN.
UR - http://www.scopus.com/inward/record.url?scp=77952744721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952744721&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2009.10.030
DO - 10.1016/j.urology.2009.10.030
M3 - Article
C2 - 20035985
AN - SCOPUS:77952744721
VL - 75
SP - 1335
EP - 1342
JO - Urology
JF - Urology
SN - 0090-4295
IS - 6
ER -